دورية أكاديمية

Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.

التفاصيل البيبلوغرافية
العنوان: Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
المؤلفون: Burton JK; Academic Geriatric Medicine, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Craig L; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Yong SQ; MVLS, College of Medicine and Veterinary Life Sciences, University of Glasgow, Glasgow, UK., Siddiqi N; Department of Health Sciences, University of York, York, UK., Teale EA; Academic Unit of Elderly Care and Rehabilitation, University of Leeds, Bradford, UK., Woodhouse R; Department of Health Sciences, Hull York Medical School, University of York, York, UK., Barugh AJ; Department of Geriatric Medicine, University of Edinburgh, Edinburgh, UK., Shepherd AM; Medicine for the Elderly, Glasgow Royal Infirmary, Glasgow, UK., Brunton A; Royal Alexandra Hospital, Paisley, UK., Freeman SC; Department of Health Sciences, University of Leicester, Leicester, UK., Sutton AJ; Department of Health Sciences, University of Leicester, Leicester, UK., Quinn TJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
المصدر: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Nov 26; Vol. 11. Cochrane AN: CD013307. Date of Electronic Publication: 2021 Nov 26.
نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE
أسماء مطبوعة: Publication: 2004- : Chichester, West Sussex, England : Wiley
Original Publication: Oxford, U.K. ; Vista, CA : Update Software,
مواضيع طبية MeSH: Delirium*/prevention & control , Medication Review*, Adult ; Hospitalization ; Humans ; Incidence ; Inpatients
مستخلص: Background: Delirium is an acute neuropsychological disorder that is common in hospitalised patients. It can be distressing to patients and carers and it is associated with serious adverse outcomes. Treatment options for established delirium are limited and so prevention of delirium is desirable. Non-pharmacological interventions are thought to be important in delirium prevention.  OBJECTIVES: To assess the effectiveness of non-pharmacological interventions designed to prevent delirium in hospitalised patients outside intensive care units (ICU).
Search Methods: We searched ALOIS, the specialised register of the Cochrane Dementia and Cognitive Improvement Group, with additional searches conducted in MEDLINE, Embase, PsycINFO, CINAHL, LILACS, Web of Science Core Collection, ClinicalTrials.gov and the World Health Organization Portal/ICTRP to 16 September 2020. There were no language or date restrictions applied to the electronic searches, and no methodological filters were used to restrict the search.
Selection Criteria: We included randomised controlled trials (RCTs) of single and multicomponent non-pharmacological interventions for preventing delirium in hospitalised adults cared for outside intensive care or high dependency settings. We only included non-pharmacological interventions which were designed and implemented to prevent delirium.  DATA COLLECTION AND ANALYSIS: Two review authors independently examined titles and abstracts identified by the search for eligibility and extracted data from full-text articles. Any disagreements on eligibility and inclusion were resolved by consensus. We used standard Cochrane methodological procedures. The primary outcomes were: incidence of delirium; inpatient and later mortality; and new diagnosis of dementia. We included secondary and adverse outcomes as pre-specified in the review protocol. We used risk ratios (RRs) as measures of treatment effect for dichotomous outcomes and between-group mean differences for continuous outcomes. The certainty of the evidence was assessed using GRADE. A complementary exploratory analysis was undertaker using a Bayesian component network meta-analysis fixed-effect model to evaluate the comparative effectiveness of the individual components of multicomponent interventions and describe which components were most strongly associated with reducing the incidence of delirium.
Main Results: We included 22 RCTs that recruited a total of 5718 adult participants. Fourteen trials compared a multicomponent delirium prevention intervention with usual care. Two trials compared liberal and restrictive blood transfusion thresholds. The remaining six trials each investigated a different non-pharmacological intervention. Incidence of delirium was reported in all studies.  Using the Cochrane risk of bias tool, we identified risks of bias in all included trials. All were at high risk of performance bias as participants and personnel were not blinded to the interventions. Nine trials were at high risk of detection bias due to lack of blinding of outcome assessors and three more were at unclear risk in this domain.  Pooled data showed that multi-component non-pharmacological interventions probably reduce the incidence of delirium compared to usual care (10.5% incidence in the intervention group, compared to 18.4% in the control group, risk ratio (RR) 0.57, 95% confidence interval (CI) 0.46 to 0.71, I 2 = 39%; 14 studies; 3693 participants; moderate-certainty evidence, downgraded due to risk of bias).  There may be little or no effect of multicomponent interventions on inpatient mortality compared to usual care (5.2% in the intervention group, compared to 4.5% in the control group, RR 1.17, 95% CI 0.79 to 1.74, I 2 = 15%; 10 studies; 2640 participants; low-certainty evidence downgraded due to inconsistency and imprecision).  No studies of multicomponent interventions reported data on new diagnoses of dementia.  Multicomponent interventions may result in a small reduction of around a day in the duration of a delirium episode (mean difference (MD) -0.93, 95% CI -2.01 to 0.14 days, I 2 = 65%; 351 participants; low-certainty evidence downgraded due to risk of bias and imprecision). The evidence is very uncertain about the effect of multicomponent interventions on delirium severity (standardised mean difference (SMD) -0.49, 95% CI -1.13 to 0.14, I 2 =64%; 147 participants; very low-certainty evidence downgraded due to risk of bias and serious imprecision). Multicomponent interventions may result in a reduction in hospital length of stay compared to usual care (MD -1.30 days, 95% CI -2.56 to -0.04 days, I 2 =91%; 3351 participants; low-certainty evidence downgraded due to risk of bias and inconsistency), but little to no difference in new care home admission at the time of hospital discharge (RR 0.77, 95% CI 0.55 to 1.07; 536 participants; low-certainty evidence downgraded due to risk of bias and imprecision). Reporting of other adverse outcomes was limited.  Our exploratory component network meta-analysis found that re-orientation (including use of familiar objects), cognitive stimulation and sleep hygiene were associated with reduced risk of incident delirium. Attention to nutrition and hydration, oxygenation, medication review, assessment of mood and bowel and bladder care were probably associated with a reduction in incident delirium but estimates included the possibility of no benefit or harm.  Reducing sensory deprivation, identification of infection, mobilisation and pain control all had summary estimates that suggested potential increases in delirium incidence, but the uncertainty in the estimates was substantial.  Evidence from two trials suggests that use of a liberal transfusion threshold over a restrictive transfusion threshold probably results in little to no difference in incident delirium (RR 0.92, 95% CI 0.62 to 1.36; I 2 = 9%; 294 participants; moderate-certainty evidence downgraded due to risk of bias).  Six other interventions were examined, but evidence for each was limited to single studies and we identified no evidence of delirium prevention.  AUTHORS' CONCLUSIONS: There is moderate-certainty evidence regarding the benefit of multicomponent non-pharmacological interventions for the prevention of delirium in hospitalised adults, estimated to reduce incidence by 43% compared to usual care. We found no evidence of an effect on mortality. There is emerging evidence that these interventions may reduce hospital length of stay, with a trend towards reduced delirium duration, although the effect on delirium severity remains uncertain. Further research should focus on implementation and detailed analysis of the components of the interventions to support more effective, tailored practice recommendations.
(Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.)
التعليقات: Comment in: J Urol. 2022 Jun;207(6):1325-1327. (PMID: 35319258)
References: Ann Intern Med. 1990 Dec 15;113(12):941-8. (PMID: 2240918)
Trials. 2015 Oct 14;16:464. (PMID: 26466809)
Clin Ther. 2015 Dec 1;37(12):2641-50. (PMID: 26598177)
Arch Intern Med. 2008 Jan 14;168(1):27-32. (PMID: 18195192)
Appl Clin Inform. 2012 Mar 07;3(1):94-102. (PMID: 23616902)
Int J Geriatr Psychiatry. 2013 Aug;28(8):804-12. (PMID: 23112139)
Am J Med. 1998 Nov;105(5):380-4. (PMID: 9831421)
Age Ageing. 2020 Jul 1;49(4):640-647. (PMID: 32307515)
Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919)
J Am Geriatr Soc. 2000 Dec;48(12):1697-706. (PMID: 11129764)
J Am Geriatr Soc. 2017 May;65(5):1026-1033. (PMID: 28039852)
J Pain Symptom Manage. 1997 Mar;13(3):128-37. (PMID: 9114631)
Drugs. 2017 Oct;77(15):1623-1643. (PMID: 28864877)
Palliat Med. 2018 Apr;32(4):733-743. (PMID: 29343167)
J Am Geriatr Soc. 2019 Feb;67(2):352-356. (PMID: 30423197)
Md State Med J. 1965 Feb;14:61-5. (PMID: 14258950)
BMC Res Notes. 2012 Jul 16;5:355. (PMID: 22800378)
Eur Respir J. 2001 Oct;18(4):630-4. (PMID: 11716166)
Age Ageing. 2009 Jan;38(1):19-26. (PMID: 19017678)
J Palliat Med. 2020 Oct;23(10):1314-1322. (PMID: 32343634)
J Clin Nurs. 2004 Sep;13(6B):91-6. (PMID: 15724823)
J Am Geriatr Soc. 2008 Aug;56(8):1479-84. (PMID: 18547359)
J Geriatr Psychiatry Neurol. 1998 Fall;11(3):126-37; discussion 157-8. (PMID: 9894731)
J Am Med Dir Assoc. 2018 Jan;19(1):12-17. (PMID: 28757330)
Psychiatry Res. 1988 Jan;23(1):89-97. (PMID: 3363018)
J Neuroinflammation. 2017 Nov 14;14(1):221. (PMID: 29137628)
J Adv Nurs. 2019 Mar;75(3):502-516. (PMID: 30230564)
JAMA. 1963 Sep 21;185:914-9. (PMID: 14044222)
J Am Med Dir Assoc. 2016 Aug 1;17(8):748-53. (PMID: 27233490)
J Am Geriatr Soc. 2020 Aug;68(8):1864-1871. (PMID: 32531089)
Ann Palliat Med. 2020 Jul;9(4):2221-2228. (PMID: 32692240)
Anesth Analg. 2020 Mar;130(3):586-595. (PMID: 31569161)
BMC Med. 2021 Jun 18;19(1):143. (PMID: 34140006)
Int Psychogeriatr. 2010 May;22(3):373-94. (PMID: 20092663)
J Clin Epidemiol. 2018 Jun;98:105-116. (PMID: 29476923)
JAMA. 2010 Jul 28;304(4):443-51. (PMID: 20664045)
N Engl J Med. 1999 Mar 4;340(9):669-76. (PMID: 10053175)
J Clin Oncol. 2013 Jan 1;31(1):111-8. (PMID: 23169523)
BMC Geriatr. 2019 Dec 31;20(1):1. (PMID: 31892317)
J Am Geriatr Soc. 2008 Apr;56(4):630-5. (PMID: 18205759)
Geriatr Gerontol Int. 2013 Apr;13(2):342-50. (PMID: 22762723)
Age Ageing. 2012 Sep;41(5):629-34. (PMID: 22589080)
Acta Orthop Scand. 1999 Jun;70(3):250-5. (PMID: 10429599)
Age Ageing. 2014 May;43(3):326-33. (PMID: 24610863)
Trials. 2017 Dec 04;18(1):583. (PMID: 29202786)
J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S262-8. (PMID: 22091571)
JAMA. 1996 Mar 20;275(11):852-7. (PMID: 8596223)
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001106. (PMID: 16855960)
Asian Cardiovasc Thorac Ann. 2020 Nov;28(9):566-571. (PMID: 32757652)
Cochrane Database Syst Rev. 2017 Sep 12;9:CD006211. (PMID: 28898390)
J Clin Epidemiol. 2011 Dec;64(12):1294-302. (PMID: 21803546)
Trials. 2017 May 17;18(1):220. (PMID: 28514964)
Aging Clin Exp Res. 2007 Jun;19(3):178-86. (PMID: 17607084)
J Am Geriatr Soc. 2005 Apr;53(4):622-8. (PMID: 15817008)
Int J Geriatr Psychiatry. 2016 Apr;31(4):392-9. (PMID: 26302258)
Age Ageing. 2020 Apr 27;49(3):352-360. (PMID: 32239173)
Trials. 2018 Dec 11;19(1):676. (PMID: 30537982)
BMJ. 2002 Nov 30;325(7375):1268. (PMID: 12458242)
J Perianesth Nurs. 2019 Oct;34(5):919-928. (PMID: 31160222)
Age Ageing. 2017 Mar 1;46(2):226-231. (PMID: 27816908)
BMC Geriatr. 2013 Jul 23;13:78. (PMID: 23879226)
Ann Med. 2000 May;32(4):257-63. (PMID: 10852142)
J Crit Care. 2019 Oct;53:75-80. (PMID: 31202161)
Curr Opin Anaesthesiol. 2011 Apr;24(2):195-201. (PMID: 21386669)
J Neuropsychiatry Clin Neurosci. 2015;27(2):139-46. (PMID: 25162511)
Langenbecks Arch Surg. 2014 Jan;399(1):77-84. (PMID: 24337734)
CMAJ. 2010 Mar 23;182(5):465-70. (PMID: 19687107)
J Am Geriatr Soc. 2000 Nov;48(11):1381-8. (PMID: 11083312)
PLoS One. 2016 Feb 22;11(2):e0143364. (PMID: 26901417)
J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):415-418. (PMID: 29099916)
Nat Rev Dis Primers. 2020 Nov 12;6(1):90. (PMID: 33184265)
Dement Geriatr Cogn Disord. 1999 Sep-Oct;10(5):406-11. (PMID: 10473948)
J Am Geriatr Soc. 2013 Aug;61(8):1286-95. (PMID: 23898894)
PLoS One. 2013 Jun 19;8(6):e64834. (PMID: 23840308)
Int J Geriatr Psychiatry. 2017 May;32(5):492-508. (PMID: 28239906)
J Am Geriatr Soc. 2015 Nov;63(11):2340-8. (PMID: 26515438)
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005563. (PMID: 17443600)
N Engl J Med. 2001 Sep 27;345(13):965-70. (PMID: 11575289)
Cochrane Database Syst Rev. 2019 Apr 23;4:CD009537. (PMID: 31012953)
BMC Anesthesiol. 2018 Jan 3;18(1):1. (PMID: 29298664)
Age Ageing. 2016 Jul;45(4):493-9. (PMID: 27076525)
Lancet Neurol. 2015 Aug;14(8):823-832. (PMID: 26139023)
N Engl J Med. 2011 Dec 29;365(26):2453-62. (PMID: 22168590)
Clin Interv Aging. 2018 Oct 24;13:2127-2134. (PMID: 30425466)
Biomed Res Int. 2017;2017:1297164. (PMID: 28164113)
Cochrane Database Syst Rev. 2016 Mar 11;3:CD005563. (PMID: 26967259)
JAMA Intern Med. 2019 Jan 1;179(1):28-36. (PMID: 30419096)
Int J Geriatr Psychiatry. 2014 Jan;29(1):32-40. (PMID: 23606365)
BMC Geriatr. 2011 May 18;11:25. (PMID: 21592324)
BMJ Open. 2015 Nov 16;5(11):e007808. (PMID: 26576806)
Med Clin (Barc). 2005 Apr 16;124(14):538-40. (PMID: 15847751)
BMC Med. 2014 Apr 15;12:63. (PMID: 24735588)
Age Ageing. 2020 Jul 1;49(4):648-655. (PMID: 32310260)
Brain. 2012 Sep;135(Pt 9):2809-16. (PMID: 22879644)
J Gen Intern Med. 2012 May;27(5):561-7. (PMID: 22302355)
Anaesthesia. 2017 Dec;72(12):1456-1466. (PMID: 28940368)
Age Ageing. 2004 Sep;33(5):472-8. (PMID: 15217778)
BMC Health Serv Res. 2018 Jul 13;18(1):550. (PMID: 30005646)
Age Ageing. 2015 Mar;44(2):196-204. (PMID: 25424450)
Age Ageing. 2021 May 5;50(3):914-920. (PMID: 33320945)
J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S241-3. (PMID: 22091567)
Anesthesiology. 2012 Apr;116(4):788-96. (PMID: 22337162)
Trials. 2019 Jan 21;20(1):71. (PMID: 30665435)
Psychooncology. 2017 Mar;26(3):291-300. (PMID: 27132588)
J Am Geriatr Soc. 2001 May;49(5):516-22. (PMID: 11380742)
Int J Palliat Nurs. 2018 Nov 2;24(11):524-534. (PMID: 30457465)
Age Ageing. 2021 Sep 11;50(5):1675-1681. (PMID: 33945608)
Age Ageing. 2012 May;41(3):285-91. (PMID: 22282171)
Crit Care Med. 2001 Jul;29(7):1370-9. (PMID: 11445689)
Acta Anaesthesiol Scand. 2010 Jul;54(6):678-88. (PMID: 20236093)
Aging Clin Exp Res. 2017 Jun;29(3):459-466. (PMID: 27251666)
Maturitas. 2011 Jul;69(3):273-8. (PMID: 21600709)
Arq Bras Cardiol. 2014 Nov;103(5):391-397. (PMID: 25352459)
J Am Geriatr Soc. 2020 Dec;68(12):2947-2954. (PMID: 32902909)
Nurs Res. 1996 Nov-Dec;45(6):324-30. (PMID: 8941300)
Neurology. 2009 May 5;72(18):1570-5. (PMID: 19414723)
Orthop Nurs. 2019 Jul/Aug;38(4):244-250. (PMID: 31343628)
Age Ageing. 2015 Nov;44(6):915-7. (PMID: 26316509)
J Cardiothorac Vasc Anesth. 2015 Apr;29(2):382-8. (PMID: 25440646)
BMJ Open. 2013 Jun 20;3(6):. (PMID: 23794558)
Arch Gerontol Geriatr. 2012 May-Jun;54(3):e284-9. (PMID: 21930310)
Eur J Cardiovasc Nurs. 2014 Dec;13(6):494-505. (PMID: 24186065)
BMC Med. 2018 Dec 11;16(1):231. (PMID: 30526577)
Trials. 2017 Jul 25;18(1):350. (PMID: 28743315)
Cochrane Database Syst Rev. 2018 Nov 23;11:CD009783. (PMID: 30484283)
Alzheimers Dement. 2018 May;14(5):617-622. (PMID: 29161540)
Contemp Clin Trials. 2018 Sep;72:137-145. (PMID: 30125731)
Anaesthesia. 2017 Jun;72(6):729-736. (PMID: 28251606)
BMJ. 2011 Oct 18;343:d5928. (PMID: 22008217)
JAMA Intern Med. 2015 Apr;175(4):512-20. (PMID: 25643002)
Am J Epidemiol. 2009 May 1;169(9):1158-65. (PMID: 19258485)
J Am Geriatr Soc. 2012 Apr;60(4):733-9. (PMID: 22429099)
Br J Surg. 2017 May;104(6):679-687. (PMID: 28198997)
J Am Geriatr Soc. 2014 Dec;62(12):2398-407. (PMID: 25481973)
BMC Geriatr. 2017 Jan 9;17(1):11. (PMID: 28068906)
Cochrane Database Syst Rev. 2021 Jul 19;7:CD013307. (PMID: 34280303)
JAMA Intern Med. 2020 Jan 1;180(1):17-25. (PMID: 31633738)
F1000Res. 2018 May 22;7:623. (PMID: 30026931)
J Gen Intern Med. 2016 Oct;31(10):1164-71. (PMID: 27259291)
JAMA Surg. 2017 Sep 01;152(9):827-834. (PMID: 28538964)
Maturitas. 2016 Apr;86:86-94. (PMID: 26921934)
Trials. 2015 Aug 08;16:340. (PMID: 26253332)
J Pain Symptom Manage. 2005 Apr;29(4):368-75. (PMID: 15857740)
J Fam Pract. 1999 Jun;48(6):417-8. (PMID: 10386480)
Trials. 2018 Aug 14;19(1):439. (PMID: 30107819)
Lancet. 2014 Mar 8;383(9920):911-22. (PMID: 23992774)
Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):181-5. (PMID: 24745810)
BMC Geriatr. 2012 Jul 20;12:36. (PMID: 22817102)
Trials. 2018 Sep 17;19(1):496. (PMID: 30223870)
J Am Geriatr Soc. 1991 Jul;39(7):655-62. (PMID: 2061530)
Int J Clin Pract. 2014 Mar;68(3):290-3. (PMID: 24118661)
J Neurosurg Anesthesiol. 2019 Apr;31(2):212-217. (PMID: 30557230)
Am J Med. 1999 May;106(5):565-73. (PMID: 10335730)
Vasc Med. 2017 Oct;22(5):387-397. (PMID: 28784053)
BMJ Open. 2013 Jan 07;3(1):. (PMID: 23299110)
Palliat Med. 2012 Oct;26(7):887-96. (PMID: 21908522)
Am J Geriatr Psychiatry. 2018 Oct;26(10):1015-1033. (PMID: 30076080)
J Am Geriatr Soc. 2017 Mar;65(3):567-573. (PMID: 27874185)
J Cardiovasc Nurs. 2017 Jan/Feb;32(1):E1-E10. (PMID: 27306854)
J Clin Epidemiol. 1994 Nov;47(11):1245-51. (PMID: 7722560)
BMJ Open. 2020 Feb 5;10(2):e034551. (PMID: 32029497)
Prof Inferm. 2007 Oct-Dec;60(4):230-6. (PMID: 18289495)
J Alzheimers Dis. 2018;64(3):775-785. (PMID: 29966197)
BMJ Open. 2019 Jan 28;9(1):e026177. (PMID: 30696686)
Trials. 2019 Aug 30;20(1):543. (PMID: 31470912)
J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. (PMID: 11449030)
تواريخ الأحداث: Date Created: 20211126 Date Completed: 20211206 Latest Revision: 20230216
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8623130
DOI: 10.1002/14651858.CD013307.pub3
PMID: 34826144
قاعدة البيانات: MEDLINE
الوصف
تدمد:1469-493X
DOI:10.1002/14651858.CD013307.pub3